Intra-Cellular Therapies Revenue (TTM) Analysis

Intra-Cellular Therapies Inc (ITCI)

90.81 +0.30 (+0.33%) USD | NASDAQ | Nov 08, 12:59

Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
September 30, 2024	612.78M
June 30, 2024	563.44M
March 31, 2024	512.29M
December 31, 2023	462.18M
September 30, 2023	418.10M
June 30, 2023	364.16M
March 31, 2023	309.11M
December 31, 2022	249.13M
September 30, 2022	187.22M
June 30, 2022	136.95M
March 31, 2022	100.88M
December 31, 2021	81.71M
September 30, 2021	68.60M
June 30, 2021	54.36M
March 31, 2021	37.23M
December 31, 2020	22.53M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2019

Date	Value
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017	0.2458M
September 30, 2017	0.3387M
June 30, 2017	0.3123M
March 31, 2017	0.426M
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015	0.2212M
March 31, 2015	0.3831M
December 31, 2014	0.5475M
September 30, 2014	1.339M
June 30, 2014	1.882M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

22.53M

Minimum

Dec 2020

612.78M

Maximum

Sep 2024

261.29M

Average

218.17M

Median

Revenue (TTM) Benchmarks